{"id":40714,"date":"2025-09-09T08:20:50","date_gmt":"2025-09-09T06:20:50","guid":{"rendered":"https:\/\/www.striped-giraffe.com\/blog\/zentrale-treiber-der-cloud-adoption-in-pharma-und-life-sciences\/"},"modified":"2025-10-16T14:15:13","modified_gmt":"2025-10-16T12:15:13","slug":"key-drivers-of-cloud-adoption-in-pharma-and-life-sciences","status":"publish","type":"post","link":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/","title":{"rendered":"Key Drivers of Cloud Adoption in Pharma and Life Sciences"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;1\/3&#8243;][\/vc_column][vc_column width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h3 style=\"font-weight: bold; color: #ef6c00;\">The adoption of cloud computing in the pharmaceutical industry means operating in one of the world\u2019s most stringent and heavily regulated environments. However, companies that are mastering this complexity are already demonstrating that innovation and compliance can go hand in hand \u2014 provided that cloud computing is used strategically and not viewed as a panacea.<\/h3>\n<p>[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h2><strong>Executive Summary<\/strong><\/h2>\n<ul>\n<li><strong>Over 80% of leading life sciences companies<\/strong> have already migrated critical workloads to the cloud.<\/li>\n<li>The life sciences cloud market is expected to reach <strong>USD 9 billion by 2030<\/strong>.<\/li>\n<li><strong>Key drivers<\/strong> include exploding data volumes, on-demand high-performance computing, AI-enabled research, global collaboration, and stringent regulatory requirements.<\/li>\n<li>Cloud adoption is not only about <strong>cost and flexibility<\/strong> \u2013 it has become a <strong>strategic enabler<\/strong> for innovation, compliance, and new business models in pharma and life sciences.<\/li>\n<li>Hybrid approaches that combine cloud agility with the control of local systems are becoming increasingly popular.<\/li>\n<\/ul>\n<p>Global studies show that more than <strong>80% of top life sciences companies have already moved critical workloads into the cloud<\/strong>, ranging from research pipelines to enterprise resource planning systems. Analysts expect the life sciences cloud market to surpass <strong>USD 9 billion by 2030<\/strong>, driven by the exponential growth of data, the urgency of faster R&amp;D, and the demand for real-time collaboration across a highly distributed ecosystem.<\/p>\n<p>Unlike many other industries, pharma faces unique challenges:<\/p>\n<ul>\n<li>strict regulatory oversight<\/li>\n<li>intellectual property protection<\/li>\n<li>the need to handle sensitive patient data with the highest standards of confidentiality<\/li>\n<\/ul>\n<p>Cloud adoption is therefore not just about cost or flexibility. It is about enabling <strong>new ways of working<\/strong> \u2014 from AI-driven drug discovery to federated data sharing across global consortia \u2014 while staying compliant with <strong>EMA<\/strong>, <strong>FDA<\/strong>, and <strong>GDPR<\/strong> requirements.<\/p>\n<p>This article highlights the key drivers of cloud adoption in pharmaceuticals and life sciences\u2014and shows why hybrid models are the most realistic option for many companies.[\/vc_column_text][vc_column_text]<\/p>\n<h2><strong>Exploding Data Volumes<\/strong><\/h2>\n<p>Pharmaceutical research generates unprecedented volumes of data \u2014 from genomics and proteomics to real-world evidence and connected manufacturing equipment. Traditional on-premises infrastructures struggle not only with the <strong>scale<\/strong> but also with the <strong>heterogeneity<\/strong> of these sources.<\/p>\n<p>The challenge is compounded by the rise of <strong>unstructured data<\/strong> such as lab notes, medical images, sensor feeds, and electronic health records. These datasets are essential for discovery and clinical insight, yet they cannot be efficiently managed with traditional relational databases or siloed storage.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud-native data architectures provide the flexibility to ingest, organize, and analyze both structured and unstructured datasets at scale. <strong>Data lakes<\/strong> and <strong>data lakehouses<\/strong> enable pharma companies to centralize genomics files, imaging datasets, and real-world evidence into a single, queryable environment.<\/p>\n<p>Combined with <strong>scalable compute<\/strong>, these models allow researchers to run advanced analytics and AI pipelines without overwhelming local infrastructure. The result is a more unified data foundation that supports faster discovery and better downstream decision-making.<\/p>\n<h3><strong>Challenge<\/strong><\/h3>\n<p>Data classification, governance, and security models must be carefully defined to meet regulatory requirements.<br \/>\n[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757349391258{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Regeneron Genetics Center<\/strong> built one of the world\u2019s largest genomics analytics environments on <strong>AWS<\/strong>, processing millions of exomes and petabyte-scale datasets to power discovery of gene\u2013disease associations at speed and scale that would be difficult on traditional on-prem systems.[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_single_image image=&#8221;40704&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h2><strong>High-Performance Computing for Research<\/strong><\/h2>\n<p>Drug discovery increasingly depends on compute-heavy workloads such as protein folding, molecular modeling, and advanced simulations. Building and maintaining such infrastructure in-house is costly and inflexible.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud <strong>high-performance computing (HPC)<\/strong> provides scalable clusters that researchers can access on demand, dramatically reducing the time and cost of computational experiments.<\/p>\n<h3><strong>Boundary<\/strong><\/h3>\n<p>For very stable, consistently high computing loads, on-premises HPC systems may still be more cost-effective.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757397644267{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>AstraZeneca<\/strong> runs large-scale genomics pipelines and computational chemistry on <strong>AWS HPC<\/strong>, enabling rapid burst capacity for sequencing and bioinformatics workloads and materially shortening time to scientific results.[\/vc_column_text][vc_column_text]<\/p>\n<h2><strong>Advanced Analytics and AI<\/strong><\/h2>\n<p>Artificial intelligence and machine learning are central to modern pharma, from predicting drug-target interactions to analyzing imaging data. These workloads require both scalable compute and advanced data governance.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud providers offer managed ML platforms, automation pipelines, and AI-specific services that make these processes faster to deploy and validate.<br \/>\n[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757397730970{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Merck<\/strong> leveraged <strong>AWS SageMaker<\/strong> and <strong>HealthOmics<\/strong> for protein modeling and manufacturing analytics, reducing false positives in quality control and accelerating drug discovery pipelines.[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_single_image image=&#8221;40702&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h2><strong>Speed and Agility<\/strong><\/h2>\n<p>Time is critical in the pharmaceutical industry. Whether it is launching a new drug, validating a manufacturing process, or running a clinical trial, delays translate into lost revenue and slower patient access to treatments.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud infrastructure can be provisioned in hours instead of weeks, giving pharma organizations the agility to experiment, test, and deploy new solutions faster.<\/p>\n<h3><strong>Boundary<\/strong><\/h3>\n<p>Critical core systems often remain deliberately local in order to ensure regulatory security and business continuity.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398119456{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Moderna<\/strong> architected its \u201cdigital-first biotech\u201d on <strong>AWS<\/strong>, scaling R&amp;D, manufacturing, and analytics workloads on demand \u2014 a foundation the company credits with accelerating development and global rollout of its mRNA platform.[\/vc_column_text][vc_column_text]<\/p>\n<h2><strong>Global Collaboration<\/strong><\/h2>\n<p>Pharmaceutical research and development is by nature distributed. Large pharma companies work across multiple sites and time zones, often in partnership with contract research organizations, academic institutions, technology providers, and regulators. Ensuring that these diverse stakeholders can collaborate effectively is essential to shorten development timelines and improve research quality.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud-based platforms enable this kind of cooperation by providing controlled environments where teams can access standardized data and tools in real time, regardless of geography or organizational boundaries.<\/p>\n<h3><strong>Pragmatic approach<\/strong><\/h3>\n<p>Hybrid models ensure that particularly sensitive data remains local and only results are shared.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398235031{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Novartis<\/strong> partnered with <strong>Microsoft<\/strong> to establish an <strong>AI Innovation Lab<\/strong> on <strong>Azure<\/strong>. The initiative created a shared digital environment where internal and external teams could collaborate on analytics and machine learning use cases, streamlining data access and fostering innovation across global operations.[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_single_image image=&#8221;40710&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h2><strong>Secure Data Sharing<\/strong><\/h2>\n<p>Data sharing has become a critical enabler of progress in today\u2019s pharma. Whether in precompetitive collaborations, public\u2013private research consortia, or multi-sponsor clinical trials, no single organization can generate the diversity and scale of data required to fuel modern science. Sharing data accelerates discovery, improves the robustness of clinical evidence, and allows companies and institutions to pool insights that would be impossible to achieve in isolation.<\/p>\n<p>At the same time, sharing sensitive research data \u2014 clinical records, compound libraries, or patient information \u2014 requires careful handling to protect confidentiality, intellectual property, and compliance. The challenge lies in enabling knowledge exchange across organizations <strong>without exposing raw datasets<\/strong>. Federated learning is one approach that helps achieve this balance.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p><strong>Federated learning<\/strong> itself is a machine learning paradigm, but in pharma it is typically deployed on cloud infrastructure that provides the secure orchestration, elastic compute power, and regulatory-grade compliance required for multi-party collaboration.<\/p>\n<p>In federated learning, instead of pooling data into a single repository, each organization keeps information within its own environment. Algorithms are sent to the data, trained locally, and only the learned parameters are shared back to a central model hosted in the cloud.<\/p>\n<p>By running training locally while using the cloud to coordinate and aggregate models, companies can unlock collective insights without ever moving raw data.<\/p>\n<h3><strong>Challenge<\/strong><\/h3>\n<p>Only cloud infrastructures that comply with regulatory requirements are suitable for this purpose.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398377560{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p>The <strong>MELLODDY<\/strong> consortium, involving ten leading pharmaceutical companies, demonstrated this approach by training machine learning models across billions of confidential data points. Using a federated cloud-based setup, the partners improved predictive performance in drug discovery while ensuring that no proprietary datasets ever left the companies\u2019 own environments.[\/vc_column_text][vc_column_text]<\/p>\n<h2><strong>Compliance and Auditability<\/strong><\/h2>\n<p>Pharma operates under some of the world\u2019s most demanding compliance regimes, including GxP, 21 CFR Part 11, and EMA guidance.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud platforms support compliance with automated audit logs, traceable data flows, and infrastructure as code \u2014 reducing the manual burden of validation and increasing transparency.<\/p>\n<h3><strong>Challenge<\/strong><\/h3>\n<p>Companies remain responsible for ensuring that cloud environments are recognized and validated by regulators.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398502854{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Roche Diagnostics<\/strong> adopted <strong>Signals Notebook<\/strong>, a cloud-based <strong>Electronic Laboratory Notebook (ELN)<\/strong>, to support regulated research and diagnostics workflows. Unlike traditional on-prem systems, the cloud ELN comes with built-in <strong>GxP validation packages<\/strong>, automated audit trails, and compliance with <strong>21 CFR Part 11<\/strong> requirements for electronic records and signatures. This ensures that every experimental record is secure, traceable, and regulator ready. By moving this critical function into the cloud, Roche simplified global access for its scientists while maintaining the level of documentation rigor expected by the <strong>FDA<\/strong> and <strong>EMA<\/strong>.[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_single_image image=&#8221;40712&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221;][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h2><strong>Manufacturing and Quality Control<\/strong><\/h2>\n<p>In pharmaceutical production, quality assurance is mission critical. Manual inspection processes are slow, resource-intensive, and prone to human error.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud-enabled machine learning models can automate anomaly detection, improving both efficiency and product safety.<\/p>\n<h3><strong>Pragmatic approach<\/strong><\/h3>\n<p>Critical production systems remain local, while the cloud is used for analytics.[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398585847{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Novo Nordisk<\/strong> deployed ML pipelines on <strong>AWS<\/strong> to automate cartridge counting and anomaly detection, with results streamed into dashboards for operators, significantly reducing error rates in production.[\/vc_column_text][vc_column_text]<\/p>\n<h2><strong>ESG and Supply Chain Transparency<\/strong><\/h2>\n<p>Investors, regulators, and patients increasingly expect visibility into environmental, social, and governance (ESG) practices. For pharma, this means tracking emissions, energy use, and supply chain performance.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud platforms allow data from disparate systems to be consolidated, analyzed, and presented in real time, turning ESG reporting into a tool for both compliance and operational improvement.<\/p>\n<h3><strong>Boundary<\/strong><\/h3>\n<p>For stable, predictable workloads, on-premises may be more economical.<br \/>\n[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398662591{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Envirotainer<\/strong> \u2014 a global leader in temperature-controlled pharma logistics \u2014 uses <strong>Microsoft Sustainability Manager<\/strong> to automate emissions data collection and improve transparency across more than 100 airlines and 600 pharma customers, supporting ESG reporting and greener operations.[\/vc_column_text][vc_column_text]<\/p>\n<h2><strong>Cost Efficiency and Flexibility<\/strong><\/h2>\n<p>Maintaining large on-premises infrastructures ties up capital that could otherwise fund R&amp;D.<\/p>\n<h3><strong>Cloud advantage<\/strong><\/h3>\n<p>Cloud\u2019s pay-as-you-go model shifts investment to operational expense and allows organizations to scale spending in line with actual usage. This flexibility is especially valuable for companies with fluctuating compute demands, such as during peak trial phases.<br \/>\n[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1757398741669{margin-top: 40px !important;padding-top: 25px !important;padding-right: 25px !important;padding-bottom: 25px !important;padding-left: 25px !important;background-color: #f7f7f7 !important;}&#8221;]<\/p>\n<h3><strong>Example:<\/strong><\/h3>\n<p><strong>Daiichi-Sankyo<\/strong> migrated its <strong>SAP ERP<\/strong> system to <strong>AWS<\/strong>, cutting operating costs by 50% while doubling system performance \u2014 freeing resources for strategic investments.[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h2><strong>Conclusion<\/strong><\/h2>\n<p>Cloud adoption in pharma and life sciences is not a uniform journey but a balancing act between innovation, compliance, and risk management. The industry has demonstrated that the cloud can handle the scale and sensitivity of genomic research, clinical trials, manufacturing, and ESG reporting \u2014 provided that deployments are carefully designed with security and regulatory frameworks in mind.<\/p>\n<p>For CIOs and senior leaders, the lesson is clear: cloud is not simply about replacing on-prem infrastructure but about rethinking operating models. Success requires <strong>hybrid strategies<\/strong> that combine the scalability of cloud with the control of local systems, strong partnerships with trusted providers, and a clear roadmap for data governance.<\/p>\n<p>Those who master this balance will not only reduce costs and accelerate R&amp;D but also create new opportunities for collaboration, transparency, and patient trust.<br \/>\n[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][vc_column_text]<\/p>\n<h3><strong>You might also like:<\/strong><\/h3>\n<ul>\n<li>Artificial Intelligence in Pharma and Healthcare (Booklet) <a href=\"https:\/\/www.striped-giraffe.com\/en\/ai-pharma-healthcare\/\">\u00bb Read more<\/a><\/li>\n<li>Pharma\u2019s AI Readiness Index: Who Leads the Race? <a href=\"https:\/\/www.striped-giraffe.com\/en\/blog\/pharma-s-ai-readiness-index-who-leads-the-race\/\">\u00bb Read more<\/a><\/li>\n<li>ESG \u2013 It is our responsibility (E-Book) <a href=\"https:\/\/www.striped-giraffe.com\/en\/esg-ebook\/\">\u00bb Read more<\/a><\/li>\n<li>Data sharing \u2014 Challenges and Opportunities <a href=\"https:\/\/www.striped-giraffe.com\/en\/blog\/data-sharing-challenges-and-opportunities\/\">\u00bb Read more<\/a><\/li>\n<li>Data governance \u2013 the linchpin of efficient data management <a href=\"https:\/\/www.striped-giraffe.com\/en\/blog\/data-governance-advanced\/\">\u00bb Read more<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_empty_space height=&#8221;40px&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;1\/3&#8243;][\/vc_column][vc_column width=&#8221;2\/3&#8243;][vc_column_text] The adoption of cloud computing in the pharmaceutical industry means operating in one of the world\u2019s most [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[315],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v20.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Key Drivers of Cloud Adoption in Pharma and Life Sciences<\/title>\n<meta name=\"description\" content=\"Cloud empowers pharma with innovation and agility, yet legal restrictions often make a hybrid approach the smarter option.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Key Drivers of Cloud Adoption in Pharma and Life Sciences\" \/>\n<meta property=\"og:description\" content=\"Cloud empowers pharma with innovation and agility, yet legal restrictions often make a hybrid approach the smarter option.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Striped Giraffe\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-09T06:20:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-16T12:15:13+00:00\" \/>\n<meta name=\"author\" content=\"Striped Giraffe Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Striped Giraffe Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\"},\"author\":{\"name\":\"Striped Giraffe Team\",\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/person\/21314fc1f246d9b252c9fa2fbb6e85fa\"},\"headline\":\"Key Drivers of Cloud Adoption in Pharma and Life Sciences\",\"datePublished\":\"2025-09-09T06:20:50+00:00\",\"dateModified\":\"2025-10-16T12:15:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\"},\"wordCount\":2316,\"publisher\":{\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#organization\"},\"articleSection\":[\"Cloud\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\",\"url\":\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\",\"name\":\"Key Drivers of Cloud Adoption in Pharma and Life Sciences\",\"isPartOf\":{\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#website\"},\"datePublished\":\"2025-09-09T06:20:50+00:00\",\"dateModified\":\"2025-10-16T12:15:13+00:00\",\"description\":\"Cloud empowers pharma with innovation and agility, yet legal restrictions often make a hybrid approach the smarter option.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#website\",\"url\":\"https:\/\/www.striped-giraffe.com\/de\/\",\"name\":\"Striped Giraffe\",\"description\":\"Ihr zuverl\u00e4ssiger Anbieter f\u00fcr digitale Enterprise-L\u00f6sungen\",\"publisher\":{\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.striped-giraffe.com\/de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#organization\",\"name\":\"Striped Giraffe\",\"url\":\"https:\/\/www.striped-giraffe.com\/de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/giraffe_white.svg\",\"contentUrl\":\"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/giraffe_white.svg\",\"caption\":\"Striped Giraffe\"},\"image\":{\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/person\/21314fc1f246d9b252c9fa2fbb6e85fa\",\"name\":\"Striped Giraffe Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/avatar_giraffe_v2-96x96.jpg\",\"contentUrl\":\"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/avatar_giraffe_v2-96x96.jpg\",\"caption\":\"Striped Giraffe Team\"},\"url\":\"https:\/\/www.striped-giraffe.com\/en\/blog\/author\/striped-giraffe\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Key Drivers of Cloud Adoption in Pharma and Life Sciences","description":"Cloud empowers pharma with innovation and agility, yet legal restrictions often make a hybrid approach the smarter option.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/","og_locale":"en_US","og_type":"article","og_title":"Key Drivers of Cloud Adoption in Pharma and Life Sciences","og_description":"Cloud empowers pharma with innovation and agility, yet legal restrictions often make a hybrid approach the smarter option.","og_url":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/","og_site_name":"Striped Giraffe","article_published_time":"2025-09-09T06:20:50+00:00","article_modified_time":"2025-10-16T12:15:13+00:00","author":"Striped Giraffe Team","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Striped Giraffe Team","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/#article","isPartOf":{"@id":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/"},"author":{"name":"Striped Giraffe Team","@id":"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/person\/21314fc1f246d9b252c9fa2fbb6e85fa"},"headline":"Key Drivers of Cloud Adoption in Pharma and Life Sciences","datePublished":"2025-09-09T06:20:50+00:00","dateModified":"2025-10-16T12:15:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/"},"wordCount":2316,"publisher":{"@id":"https:\/\/www.striped-giraffe.com\/de\/#organization"},"articleSection":["Cloud"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/","url":"https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/","name":"Key Drivers of Cloud Adoption in Pharma and Life Sciences","isPartOf":{"@id":"https:\/\/www.striped-giraffe.com\/de\/#website"},"datePublished":"2025-09-09T06:20:50+00:00","dateModified":"2025-10-16T12:15:13+00:00","description":"Cloud empowers pharma with innovation and agility, yet legal restrictions often make a hybrid approach the smarter option.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.striped-giraffe.com\/en\/blog\/key-drivers-of-cloud-adoption-in-pharma-and-life-sciences\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.striped-giraffe.com\/de\/#website","url":"https:\/\/www.striped-giraffe.com\/de\/","name":"Striped Giraffe","description":"Ihr zuverl\u00e4ssiger Anbieter f\u00fcr digitale Enterprise-L\u00f6sungen","publisher":{"@id":"https:\/\/www.striped-giraffe.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.striped-giraffe.com\/de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.striped-giraffe.com\/de\/#organization","name":"Striped Giraffe","url":"https:\/\/www.striped-giraffe.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/giraffe_white.svg","contentUrl":"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/giraffe_white.svg","caption":"Striped Giraffe"},"image":{"@id":"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/person\/21314fc1f246d9b252c9fa2fbb6e85fa","name":"Striped Giraffe Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.striped-giraffe.com\/de\/#\/schema\/person\/image\/","url":"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/avatar_giraffe_v2-96x96.jpg","contentUrl":"https:\/\/www.striped-giraffe.com\/wp-content\/uploads\/2021\/01\/avatar_giraffe_v2-96x96.jpg","caption":"Striped Giraffe Team"},"url":"https:\/\/www.striped-giraffe.com\/en\/blog\/author\/striped-giraffe\/"}]}},"_links":{"self":[{"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/posts\/40714"}],"collection":[{"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/comments?post=40714"}],"version-history":[{"count":10,"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/posts\/40714\/revisions"}],"predecessor-version":[{"id":41486,"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/posts\/40714\/revisions\/41486"}],"wp:attachment":[{"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/media?parent=40714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/categories?post=40714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.striped-giraffe.com\/en\/wp-json\/wp\/v2\/tags?post=40714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}